Crescent Biopharma CBIO
NASDAQ CBIO
$14.49 -0.27 (-1.83%)
As of: Sep 30, 2026 · 2:32 PM EDT

Crescent Biopharma (CBIO) Accounts Payables (2013 - 2026)

Updated

Crescent Biopharma (CBIO) posted Accounts Payables of $2.54 million for Q2 2026, down 51.1% from $5.2 million a year earlier but up 113.6% from the prior quarter.

Analysis

Crescent Biopharma (CBIO) Accounts Payables (2013 - 2026) Analysis & Trends

At the end of FY2025, Crescent Biopharma's Accounts Payables came in at $10 million.

  • Annual Accounts Payables shows a five-year compound annual growth rate of 36.8% (FY2020 to FY2025).
  • In prior years, Crescent Biopharma's Accounts Payables was $329,304 in FY2024 (-62.1%), $868,115 in FY2023 (-10.5%), $970,191 in FY2022 (-54.0%) and $2.11 million in FY2021 (+0.8%).
  • Quarterly Accounts Payables has run from a low of $104,671 in Q1 2025 to a high of $10 million in Q4 2025 over five years.
  • On a year-over-year basis, Accounts Payables increased in three of the last six quarters, with growth averaging 217.8%.
  • The strongest year-over-year quarter for Accounts Payables in the past five years was Q3 2025, with growth of 982.9%; the weakest was Q1 2025, with a decline of 86.1%.
  • According to Business Quant data, Accounts Payables for the three prior quarters was $1.19 million (Q1 2026), $10 million (Q4 2025) and $6.3 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 9.22 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 33.30 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -22.89 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 674.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 429.50 Mn
10 Crescent Biopharma 409.68 Mn -297.61 Mn - 2.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.54 Mn
Mar 31, 2026 1.19 Mn
Dec 31, 2025 10.00 Mn
Sep 30, 2025 6.30 Mn
Jun 30, 2025 5.20 Mn
Mar 31, 2025 104,671.00
Dec 31, 2024 329,304.00
Sep 30, 2024 581,794.00
Jun 30, 2024 950,763.00
Mar 31, 2024 755,534.00
Dec 31, 2023 868,115.00
Sep 30, 2023 329,885.00
Jun 30, 2023 241,487.00
Mar 31, 2023 480,151.00
Dec 31, 2022 970,191.00
Sep 30, 2022 852,125.00
Jun 30, 2022 1.27 Mn
Mar 31, 2022 2.28 Mn
Dec 31, 2021 2.11 Mn
Sep 30, 2021 1.39 Mn
API Access

Crescent Biopharma Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=CBIO&period=max&api_key=YOUR_API_KEY